Annual Retained Earnings
-$70.37 M
-$12.17 M-20.91%
01 December 2023
Summary:
NLS Pharmaceutics AG annual retained earnings is currently -$70.37 million, with the most recent change of -$12.17 million (-20.91%) on 01 December 2023. During the last 3 years, it has fallen by -$40.61 million (-136.47%). NLSP annual retained earnings is now -331.62% below its all-time high of -$16.30 million, reached on 31 December 2017.NLSP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$72.41 M
-$2.04 M-2.89%
01 June 2024
Summary:
NLS Pharmaceutics AG quarterly retained earnings is currently -$72.41 million, with the most recent change of -$2.04 million (-2.89%) on 01 June 2024. Over the past year, it has dropped by -$6.60 million (-10.02%). NLSP quarterly retained earnings is now -237.56% below its all-time high of -$21.45 million, reached on 31 December 2018.NLSP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.9% | -10.0% |
| 3 y3 years | -136.5% | -110.7% |
| 5 y5 years | -228.1% | -191.2% |
NLSP Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -136.5% | at low | -110.7% | at low |
| 5 y | 5 years | -228.1% | at low | -191.2% | at low |
| alltime | all time | -331.6% | at low | -237.6% | at low |
NLS Pharmaceutics AG Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$72.41 M(+2.9%) |
| Dec 2023 | -$70.37 M(+20.9%) | -$70.37 M(+6.9%) |
| June 2023 | - | -$65.81 M(+13.1%) |
| Dec 2022 | -$58.20 M(+39.6%) | -$58.20 M(+15.6%) |
| June 2022 | - | -$50.35 M(+20.7%) |
| Dec 2021 | -$41.71 M | -$41.71 M(+21.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | -$34.36 M(+15.5%) |
| Dec 2020 | -$29.76 M(+10.6%) | -$29.76 M(+5.8%) |
| June 2020 | - | -$28.13 M(+4.6%) |
| Dec 2019 | -$26.90 M(+25.4%) | -$26.90 M(+8.2%) |
| June 2019 | - | -$24.87 M(+15.9%) |
| Dec 2018 | -$21.45 M(+31.6%) | -$21.45 M |
| Dec 2017 | -$16.30 M | - |
FAQ
- What is NLS Pharmaceutics AG annual retained earnings?
- What is the all time high annual retained earnings for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual retained earnings year-on-year change?
- What is NLS Pharmaceutics AG quarterly retained earnings?
- What is the all time high quarterly retained earnings for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly retained earnings year-on-year change?
What is NLS Pharmaceutics AG annual retained earnings?
The current annual retained earnings of NLSP is -$70.37 M
What is the all time high annual retained earnings for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual retained earnings is -$16.30 M
What is NLS Pharmaceutics AG annual retained earnings year-on-year change?
Over the past year, NLSP annual retained earnings has changed by -$12.17 M (-20.91%)
What is NLS Pharmaceutics AG quarterly retained earnings?
The current quarterly retained earnings of NLSP is -$72.41 M
What is the all time high quarterly retained earnings for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly retained earnings is -$21.45 M
What is NLS Pharmaceutics AG quarterly retained earnings year-on-year change?
Over the past year, NLSP quarterly retained earnings has changed by -$6.60 M (-10.02%)